Limiting reimbursement for blood glucose test strips does not harm patients and reduces costs

Our priority is to ensure the safety and well-being of our patients and residents, and our people.

Only pre-approved visitors can visit patients at our sites. Please check our COVID-19 information page to learn more about what to expect for your appointment/visit and how to be approved as a visitor. >>

Book an appointment online for COVID-19 testing at one of our Assessment Centres. >>


Our Stories

Limiting reimbursement for blood glucose test strips does not harm patients and reduces costs

Toronto, November 7, 2016

Tara Gomes

Tara Gomes

A provincial plan implementing quantity limits on blood glucose test strips for patients with Type 2 diabetes not using insulin does not put those patients at risk and has saved the province of Ontario $24 million, according to a new study published in JAMA Internal Medicine.

Self-monitoring of blood glucose for patients with diabetes on insulin is considered an essential part of their health management because they can use the results to adjust their medication throughout the day. However, for most patients with Type 2 diabetes not using insulin, frequent monitoring with blood glucose test strips is not considered clinically beneficial and may lead to decreased quality of life and well-being. For patients with diabetes who do not use insulin, it is rare for blood glucose levels to drop to dangerous levels, and so these patients generally do not need to test their blood glucose levels daily. Instead, testing just a few times a week can provide their physician with helpful information as to whether their oral medications need to be adjusted.

Earlier studies examined the total cost of test strips and found they were the third largest cost for the Ontario Public Drug Programs in 2007-08, accounting for $100 million or 3.3 per cent of drug expenditures. In 2013, the Ontario Public Drug Programs implemented a policy restricting reimbursement for blood glucose test strips that aligned with recommendations from the Canadian Diabetes Association for how often patients should be doing regular blood glucose monitoring.

“The concern around limiting blood glucose test strips was that patients would end up in the emergency department with very high or low blood glucose, but what we found was that these quantity limits were not associated with any worsening of these outcomes for patients,” said Tara Gomes, lead author of the study, a principal investigator of the Ontario Drug Policy Research Network, and a scientist at both the Institute for Clinical Evaluative Sciences and the Li Ka Shing Knowledge Institute of St. Michael’s Hospital.

The annual test strip quantity limits are: 3,000 for patients using insulin, 400 for patients on specific oral antidiabetic drugs that are known to increase the risk for low blood glucose, and 200 for all other patients with diabetes.

“This is a great example of a policy change based on evidence, where the change not only saved the province money but had no negative impact on patients. Those healthcare dollars are now available to support other programs and therapies that could improve patient outcomes,” said Gomes.

However, the researchers stress that this study assessed outcomes for only 1.5 years following the implementation of the 2013 policy, adding long-term consequences need to be studied.

“The impact of blood glucose test strip quantity limit policy on patient outcomes in Ontario. A population-based study” was published today in the JAMA Internal Medicine.

Infographic: No worse outcomes seen after limit set on reimbursed diabetes test strips - New policy saves Ontario $24 million in one year. In August 2013, Ontario set quantity limits on provincially-reimbursed test strips for type 2 diabetes. New yearly maximum of: a) 3,000 strips for patients using insulin; b) 400 strips for patients on antidiabetic drugs known to incrase risk of low blood sugar; c) 200 strips for all other patients with diabetes.
Click here or on the image above for a larger version.

This paper is an example of how St. Michael's Hospital is making Ontario Healthier, Wealthier, Smarter.

About St. Michael's Hospital

St. Michael’s Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in 27 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital’s recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

About ICES

The Institute for Clinical Evaluative Sciences is an independent, non-profit organization that uses population-based health information to produce knowledge on a broad range of health care issues. Our unbiased evidence provides measures of health system performance, a clearer understanding of the shifting health care needs of Ontarians, and a stimulus for discussion of practical solutions to optimize scarce resources. ICES knowledge is highly regarded in Canada and abroad, and is widely used by government, hospitals, planners, and practitioners to make decisions about care delivery and to develop policy. For the latest ICES news, follow us on Twitter: @ICESOntario

Media contacts

For more information, please contact:

Leslie Shepherd
Manager, Media Strategy, St. Michael's Hospital

Deborah Creatura
Media Advisor, ICES
(o) 416-480-4780 or (c) 647-406-5996

See More of Our Stories in 2016